Introduction:
The pharmaceutical industry in Brazil has been experiencing significant growth in recent years, with an increasing demand for generic drugs. Government procurement and tender agencies play a crucial role in ensuring access to affordable medications for the population. In 2020, Brazil’s generic drug market accounted for approximately 35% of the total pharmaceutical market, showing a steady increase in production and consumption.
Top 10 Generic Drug Government Procurement & Tender Agencies in Brazil:
1. Farmanguinhos – Farmanguinhos is a leading government procurement agency in Brazil, with a production volume of over 500 million units of generic drugs annually. They have a strong focus on providing essential medications at affordable prices to the Brazilian population.
2. Cristalia – Cristalia is known for its high-quality generic drugs and has a significant market share in Brazil, accounting for over 15% of the generic drug market. They have established partnerships with various government agencies for procurement and tender processes.
3. Eurofarma – Eurofarma is one of the largest pharmaceutical companies in Brazil, with a diversified portfolio of generic drugs. They have been actively participating in government tenders, securing contracts for the supply of essential medications nationwide.
4. EMS – EMS is a key player in the Brazilian generic drug market, with a wide range of products and a strong presence in government procurement. They have been consistently expanding their production capacity to meet the increasing demand for generic drugs in Brazil.
5. Teuto – Teuto is a leading manufacturer of generic drugs in Brazil, with a focus on innovation and quality. They have been actively participating in government tenders, winning contracts for the supply of essential medications to public health institutions.
6. Aché – Aché is a renowned pharmaceutical company in Brazil, with a significant market share in the generic drug segment. They have a strong presence in government procurement, supplying a wide range of medications to public health facilities across the country.
7. Biolab – Biolab is known for its expertise in developing and manufacturing generic drugs, with a production volume of over 300 million units annually. They have been actively involved in government procurement processes, ensuring the availability of essential medications for the Brazilian population.
8. Mantecorp – Mantecorp is a trusted name in the Brazilian pharmaceutical industry, with a focus on generic drugs and healthcare solutions. They have been collaborating with government procurement agencies to supply medications for public health programs and initiatives.
9. EMS Sigma Pharma – EMS Sigma Pharma is a subsidiary of EMS, specializing in the production of generic drugs for the Brazilian market. They have a strong distribution network and have secured contracts through government tenders for the supply of medications to public health institutions.
10. Germed – Germed is a leading manufacturer of generic drugs in Brazil, with a wide range of products catering to various therapeutic areas. They have been actively participating in government procurement processes, ensuring the availability of affordable medications for the Brazilian population.
Insights:
The generic drug market in Brazil is expected to continue its growth trajectory, driven by the increasing demand for affordable medications and the government’s focus on expanding access to healthcare services. With the implementation of new regulations and policies to promote the use of generic drugs, we can expect to see a further increase in the procurement and tender activities of government agencies. In 2021, the generic drug market in Brazil is projected to reach a market size of over $5 billion, highlighting the significant opportunities for pharmaceutical companies operating in this sector. As the population continues to age and the prevalence of chronic diseases rises, the demand for generic drugs is expected to remain strong, making government procurement agencies key players in ensuring access to essential medications for all Brazilians.
Related Analysis: View Previous Industry Report
